DETTE Changement Date
AbbVie USD 1000K 70.48B 2025-09
ALKERMES USD 71.6M 1.08M 2025-09
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Bausch Health Companies USD 21.04B 696M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
Prestige Brands USD 1.04B 1.7M 2025-09
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Takeda JPY 4.85T 208B 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Zoetis USD 7.27B 482M 2025-09